Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.
Journal article

Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.

Show more…
Published in:
  • Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2015, vol. 33, no. 15_suppl, p. 3068-3068
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/178907
Statistics

Document views: 14 File downloads: